Provided by Tiger Trade Technology Pte. Ltd.

Akari Therapeutics PLC

10.70
+1.6918.76%
Post-market: 10.800.1000+0.93%19:54 EDT
Volume:168.62K
Turnover:1.64M
Market Cap:20.83M
PE:-0.67
High:11.08
Open:8.93
Low:8.80
Close:9.01
52wk High:49.60
52wk Low:3.02
Shares:1.95M
Float Shares:694.50K
Volume Ratio:2.15
T/O Rate:24.28%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-15.9015
EPS(LYR):-20.5537
ROE:-140.09%
ROA:-19.10%
PB:1.12
PE(LYR):-0.52

Loading ...

Akari Therapeutics trading halted, volatility trading pause

TIPRANKS
·
May 28

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:55 AM

Reuters
·
May 28

Akari CEO touts AKTX-101 synergy data in Virtual Investor interview after ASCO abstract acceptance

Reuters
·
May 28

Akari Therapeutics trading halted, volatility trading pause

TIPRANKS
·
May 27

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:30 AM

Reuters
·
May 26

Top Premarket Decliners

MT Newswires Live
·
May 26

Stocks to Watch: Akari Therapeutics, BlackSky Technology

Dow Jones
·
May 23

Akari Therapeutics Stock (AKTX) Explodes 242% on Strong Cancer Drug Data and $5.5M Funding Boost

TIPRANKS
·
May 23

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 01:42 PM

Reuters
·
May 23

Top Midday Gainers

MT Newswires Live
·
May 23

European Equities Traded in the US as American Depositary Receipts Edge Higher in Friday Trading

MT Newswires Live
·
May 22

Top Premarket Gainers

MT Newswires Live
·
May 22

Akari reports preclinical AKTX-101 synergy with KRAS inhibitor in pancreatic cancer models

Reuters
·
May 22

Akari Therapeutics Reports Breakthrough Preclinical Data Demonstrating Synergistic Activity of Aktx-101 With Kras Inhibition in Kras-Mutated Pancreatic Cancer Models

THOMSON REUTERS
·
May 22

Akari Therapeutics Plc - Initiates Ind-Enabling Studies for Aktx-101, Targets Phase 1 Trial by Mid-2027

THOMSON REUTERS
·
May 22

European Equities Traded in the US as American Depositary Receipts Little Changed in Thursday Trading

MT Newswires Live
·
May 21

Akari Therapeutics prices $5.5 million unregistered private placement at $3.74 ADS

Reuters
·
May 21

Akari Therapeutics Plc - Gross Proceeds to Be Funded in Three Tranches Between May 27 and July 15, 2026

THOMSON REUTERS
·
May 21

Akari Therapeutics Announces $5.5 Million Private Placement Offering

THOMSON REUTERS
·
May 21

Akari Therapeutics Faces Risk of Further IPR&D Write‑Downs on AKTX‑101 and ADC Platform

TIPRANKS
·
May 21